CONMED Corp — Director's Dealing 2012

Apr 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-04-09

Reporting Person: CORASANTI JOSEPH J (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-09	Common Stock	M	15000	$17.74	Acquired	92161	Direct
2012-04-09	Common Stock	S	15000	$29.5636	Disposed	77161	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-09	Options To Purchase Common Stock	$17.74	M	15000	Disposed	2013-05-20	Common Stock (15000)	Direct

Footnotes

F1: 5 year vesting schedule, 20% vest each year starting 5/20/2004.

F2: The price reported in Column 4 is a weighted average price. These prices were sold in multiple transactions at prices ranging from $29.45 to $29.69. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 15, 2012.